To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene VAPATABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
421 supporting clones for gene VAPA back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DA202612 brain .a 1 to 562 2 to 563   tiling clone, capped   562/563
(99 %)
2 diff
(99.7 %id)
DA592224 lung .a 33 to 515 2 to 490   capped   489/490
(99 %)
12 diff
(97.6 %id)
NM_003574.5   .a 280 to 7273 1 to 6994 exact RefSeq,   6994/6994
(100 %)
0 diff
(100 %id)
BG719406 testis .a 304 to 1014 1 to 712       712/713
(99 %)
9 diff
(98.8 %id)
BG393881 embryonal carcinoma, cell line, testis .a 384 to 1130 1 to 749       749/760
(98 %)
8 diff
(99.0 %id)
CX757763 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 398 to 1130 32 to 754   tiling clone, Submitted on the opposite strand 723/802
(90 %)
14 diff
(98.3 %id)
DR006703 Spleen .a 437 to 1082 1 to 646       646/646
(100 %)
5 diff
(99.3 %id)
BG720000 testis .a 538 to 1246 1 to 707       707/707
(100 %)
9 diff
(98.8 %id)
AV698439 hepatocellular carcinoma .a 574 to 1192 1 to 611       611/654
(93 %)
23 diff
(96.5 %id)
BX460166 brain, fetal brain .a 641 to 1305 250 to 921       672/1053
(63 %)
25 diff
(97.7 %id)
BG210596   .a 997 to 1610 1 to 605   tiling clone,   605/609
(99 %)
25 diff
(95.9 %id)
BI036671 nervous_tumor .a 1033 to 1442 19 to 429       411/429
(95 %)
1 diff
(99.8 %id)
BF825100 head_normal .a 1049 to 1456 26 to 429       404/429
(94 %)
4 diff
(99.1 %id)
BI036673 nervous_tumor .a 1051 to 1456 30 to 434       405/434
(93 %)
0 diff
(100 %id)
BF850880 lung_normal .a 1063 to 1485 11 to 429   tiling clone,   419/429
(97 %)
1 diff
(99.8 %id)
BG204074   .a 1129 to 1893 1 to 763   tiling clone,   763/772
(98 %)
15 diff
(98.1 %id)
BX434796 brain, fetal brain .a 1299 to 2063 771 to 5   tiling clone,   767/899
(85 %)
0 diff
(100 %id)
BP209270 cerebellum .b 1 to 577 1 to 577   tiling clone,   577/577
(100 %)
0 diff
(100 %id)
NM_194434.2   .b 1 to 6859 1 to 6859 exact RefSeq,   6859/6859
(100 %)
0 diff
(100 %id)
DA418824 thalamus .b 2 to 546 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA802716 brain .b 34 to 596 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
BP257433 heart .b 37 to 620 1 to 584       584/584
(100 %)
0 diff
(100 %id)
DA635656 Kidney .b 38 to 612 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
CR592788 placenta .b 45 to 1638 1 to 1594 exact     1594/1594
(100 %)
0 diff
(100 %id)
DA130077 alzheimer cortex .b 48 to 676 2 to 630   capped   629/629
(100 %)
0 diff
(100 %id)
CN276175 embryonic stem cells, DMSO-treated H9 cellline .b 48 to 766 1 to 719       719/719
(100 %)
1 diff
(99.9 %id)
DA006736   .b 50 to 624 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
CR615746 Placenta Cot 25-normalized .b 50 to 1633 1 to 1584 exact     1584/1584
(100 %)
0 diff
(100 %id)
TI_44344152   .b 55 to 811 89 to 845       759/845
(89 %)
6 diff
(99.3 %id)
CF272527 Brain glioblastoma .b 56 to 938 1 to 893       893/894
(99 %)
14 diff
(98.5 %id)
DB493556 hypothalamus .b 58 to 578 1 to 521       521/521
(100 %)
2 diff
(99.7 %id)
DA608023   .b 61 to 695 2 to 636   capped   635/635
(100 %)
0 diff
(100 %id)
AK315577 placenta .b 62 to 1049 1 to 988 exact     988/988
(100 %)
0 diff
(100 %id)
DA857742 placenta .b 63 to 599 2 to 538   capped   537/537
(100 %)
0 diff
(100 %id)
CR595148 placenta .b 65 to 1664 1 to 1600 exact tiling clone,   1600/1600
(100 %)
0 diff
(100 %id)
CR626388 neuroblastoma .b 65 to 1626 1 to 1562 exact     1562/1562
(100 %)
0 diff
(100 %id)
DB009276 colon, tumor tissue .b 65 to 620 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DA121366 cerebellum .b 67 to 603 2 to 538   capped   537/537
(100 %)
0 diff
(100 %id)
DA212188 brain .b 67 to 605 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
DA861707 placenta .b 67 to 628 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
BP203694 coronary artery .b 68 to 650 1 to 583       583/583
(100 %)
0 diff
(100 %id)
DB478678 hippocampus .b 68 to 531 1 to 464       464/465
(99 %)
1 diff
(99.8 %id)
DB480658 hippocampus .b 68 to 570 1 to 504       504/505
(99 %)
4 diff
(99.3 %id)
DA357074 subthalamic nucleus .b 69 to 635 2 to 568   capped   567/575
(98 %)
0 diff
(100 %id)
DA506710 brain .b 69 to 635 2 to 568   capped   567/575
(98 %)
0 diff
(100 %id)
DA758282   .b 69 to 617 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DB154121 thymus .b 69 to 670 2 to 603   capped   602/602
(100 %)
0 diff
(100 %id)
DB240090 trachea .b 69 to 654 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
DA241381 brain .b 71 to 665 2 to 596   capped   595/595
(100 %)
0 diff
(100 %id)
DA404198 thalamus .b 76 to 635 2 to 561   capped   560/568
(98 %)
0 diff
(100 %id)
AL534828 brain, fetal brain .b 76 to 1211 1 to 1130 K10N H11T E12S Q13R I14S ...     1130/1134
(99 %)
23 diff
(98.0 %id)
DB475313 hippocampus .b 76 to 552 1 to 477       477/477
(100 %)
0 diff
(100 %id)
DB498083 hypothalamus .b 76 to 571 1 to 496       496/496
(100 %)
0 diff
(100 %id)
DB237925 trachea .b 77 to 667 2 to 592   capped   591/591
(100 %)
0 diff
(100 %id)
DB282899 uterus .b 77 to 661 2 to 586   capped   585/585
(100 %)
0 diff
(100 %id)
DA426105 colon .b 82 to 646 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DB455961 testis .b 82 to 577 1 to 496       496/496
(100 %)
0 diff
(100 %id)
DB458621 testis .b 82 to 562 1 to 481       481/481
(100 %)
0 diff
(100 %id)
DB504942 hypothalamus .b 82 to 562 1 to 481       481/481
(100 %)
0 diff
(100 %id)
DA412127 thalamus .b 83 to 635 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
BP258240 heart .b 83 to 653 1 to 571       571/571
(100 %)
0 diff
(100 %id)
CN276174 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 84 to 784 1 to 701       701/701
(100 %)
1 diff
(99.9 %id)
BU150686 brain, neuroblastoma, cell line .b 86 to 860 1 to 782       782/861
(90 %)
18 diff
(98.0 %id)
CX868915 embryonic stem .b 86 to 844 1 to 759     Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 759/759
(100 %)
2 diff
(99.8 %id)
CX759466 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 87 to 786 1 to 700     Submitted on the opposite strand 700/700
(100 %)
0 diff
(100 %id)
DB496289 hypothalamus .b 89 to 562 1 to 474       474/474
(100 %)
1 diff
(99.8 %id)
CX781871 human embryonic stem cells .b 90 to 890 1 to 800       800/800
(100 %)
0 diff
(100 %id)
BM559801 amelanotic melanoma, cell line, skin .b 92 to 1055 1 to 968 E177G N193I R194G H195T L196*     968/1079
(89 %)
15 diff
(98.7 %id)
DB224880 trachea .b 93 to 663 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DB478325 hippocampus .b 94 to 592 1 to 499       499/499
(100 %)
0 diff
(100 %id)
BQ639388 eye, retina .b 94 to 635 1 to 542       542/542
(100 %)
0 diff
(100 %id)
BU187320 epithelioid carcinoma, Pancreas .b 94 to 890 1 to 806       806/869
(92 %)
11 diff
(98.8 %id)
DR760775 embryonic stem .b 95 to 890 1 to 795       795/795
(100 %)
0 diff
(100 %id)
BM802464 duodenal adenocarcinoma, cell line, small intestine .b 96 to 992 1 to 902       902/903
(99 %)
22 diff
(97.6 %id)
TI_57230093   .b 97 to 875 84 to 867       784/784
(100 %)
28 diff
(96.5 %id)
BP418398 small intestine .b 100 to 624 1 to 525     Submitted on the opposite strand 525/525
(100 %)
0 diff
(100 %id)
CX867411 embryonic stem .b 100 to 887 1 to 788     Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 788/788
(100 %)
0 diff
(100 %id)
CX872377 embryonic stem .b 100 to 846 1 to 747       747/747
(100 %)
0 diff
(100 %id)
BQ722976 sympathetic trunk .b 101 to 891 1 to 795       795/862
(92 %)
11 diff
(98.8 %id)
DA212392 brain .b 103 to 634 2 to 533   capped   532/532
(100 %)
0 diff
(100 %id)
DA246475 brain .b 104 to 677 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA395287 thalamus .b 108 to 687 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
DA897348 skeletal muscle .b 108 to 668 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DB030776 testis .b 108 to 688 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
BP323671 Pancreas .b 109 to 690 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BM847175 myeloma .b 109 to 669 1 to 561       561/561
(100 %)
0 diff
(100 %id)
DA860386 placenta .b 110 to 667 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
CR626025 Placenta Cot 25-normalized .b 114 to 1629 1 to 1516 exact     1516/1516
(100 %)
0 diff
(100 %id)
BQ928459 carcinoma, cell line, Prostate .b 115 to 1019 1 to 914       914/919
(99 %)
17 diff
(98.2 %id)
CN482388 eye .b 119 to 740 1 to 622       622/622
(100 %)
0 diff
(100 %id)
CA776570 Pancreas, Purified pancreatic islet .b 125 to 758 1 to 634       634/634
(100 %)
0 diff
(100 %id)
CN276180 embryonic stem cells, cell lines H1, H7, andH9 .b 126 to 817 1 to 694       694/705
(98 %)
2 diff
(99.8 %id)
CN276166 embryonic stem cells, DMSO-treated H9 cellline .b 127 to 617 1 to 491       491/491
(100 %)
0 diff
(100 %id)
CN276179 embryonic stem cells, DMSO-treated H9 cellline .b 127 to 790 1 to 664       664/664
(100 %)
0 diff
(100 %id)
CR616989 Placenta Cot 25-normalized .b 147 to 1510 1 to 1364 exact     1364/1364
(100 %)
0 diff
(100 %id)
CN276159 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 148 to 812 1 to 665       665/665
(100 %)
0 diff
(100 %id)
DR760555 embryonic stem .b 171 to 1014 1 to 844       844/844
(100 %)
1 diff
(99.9 %id)
CN276172 embryonic stem cells, cell lines H1, H7, andH9 .b 182 to 828 1 to 647       647/648
(99 %)
1 diff
(99.9 %id)
TI_45213712   .b 264 to 999 92 to 842   AAA   746/1262
(59 %)
28 diff
(97.8 %id)
AK292948 trachea .b 273 to 1991 1 to 1718 exact     1718/1718
(100 %)
1 diff
(100.0 %id)
DB230379 trachea .b 274 to 874 2 to 602   capped   601/601
(100 %)
0 diff
(100 %id)
TI_44166377   .b 281 to 1075 92 to 888 M186N M187D K188E L189A S190I ...     797/1071
(74 %)
18 diff
(98.4 %id)
CR607357 adult brain .b 282 to 1640 1 to 1359 exact     1359/1359
(100 %)
0 diff
(100 %id)
DB159114 thymus .b 283 to 838 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
AF154847   .b 284 to 1650 1 to 1367 P160S AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 1367/1367
(100 %)
1 diff
(100.0 %id)
DA402059 thalamus .b 284 to 849 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
BF692977 muscle (skeletal) .b 285 to 858 1 to 578       578/885
(65 %)
26 diff
(97.1 %id)
DB138147 thymus .b 285 to 840 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
EL955065 eyeball .b 286 to 716 48 to 473       426/484
(88 %)
2 diff
(99.6 %id)
CF994696 Human Placenta, placenta .b 286 to 965 28 to 701       674/731
(92 %)
12 diff
(98.4 %id)
TI_44345564   .b 291 to 1150 86 to 945 S216*     860/945
(91 %)
11 diff
(98.9 %id)
AW328197 Burkitt lymphoma, lymph .b 293 to 853 7 to 568       562/568
(98 %)
0 diff
(100 %id)
BM453085 leiomyosarcoma, uterus .b 293 to 877 1 to 591   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 591/912
(64 %)
13 diff
(98.6 %id)
CN276160 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 294 to 821 1 to 528       528/528
(100 %)
1 diff
(99.9 %id)
CR624715 adult brain .b 296 to 1620 1 to 1325 exact     1325/1325
(100 %)
0 diff
(100 %id)
AF044670 Liver .b 297 to 1663 1 to 1364 exact AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 1364/1364
(100 %)
5 diff
(99.7 %id)
BQ425783 leiomyosarcoma, uterus .b 299 to 1179 1 to 884 V234E I235L A236Q A237P I238F ...     884/884
(100 %)
12 diff
(98.7 %id)
BE925881 breast_normal .b 301 to 840 11 to 551       541/551
(98 %)
3 diff
(99.5 %id)
TI_1948101137   .b 314 to 681 122 to 489       368/388
(94 %)
0 diff
(100 %id)
AF057358 Pancreas .b 321 to 1049 1 to 729       729/729
(100 %)
2 diff
(99.8 %id)
AF086627   .b 321 to 1049 1 to 729       729/729
(100 %)
0 diff
(100 %id)
BT019618   .b 321 to 1049 1 to 729       729/729
(100 %)
2 diff
(99.8 %id)
CV026020 mixed .b 321 to 947 1 to 627       627/629
(99 %)
2 diff
(99.7 %id)
BG944670 blood .b 323 to 739 1 to 417       417/417
(100 %)
0 diff
(100 %id)
AA523700 ovary .b 328 to 864 1 to 535       535/535
(100 %)
31 diff
(94.3 %id)
CN276176 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 339 to 906 1 to 568       568/568
(100 %)
0 diff
(100 %id)
BM968579 lung, Primary Lung Epithelial Cells .b 355 to 1064 17 to 725     Submitted on the opposite strand 709/711
(99 %)
7 diff
(99.1 %id)
CD108072 brain, Pituitary .b 363 to 1204 25 to 869       845/869
(97 %)
6 diff
(99.4 %id)
AW608331 leiomios .b 374 to 817 453 to 14       440/453
(97 %)
0 diff
(100 %id)
BE827254 lung_tumor .b 396 to 714 344 to 25       320/344
(93 %)
8 diff
(97.7 %id)
CN276165 embryonic stem cells, DMSO-treated H9 cellline .b 403 to 1070 1 to 669       669/669
(100 %)
3 diff
(99.6 %id)
BE907380 epithelioid carcinoma, Pancreas .b 407 to 1122 1 to 708       708/930
(76 %)
9 diff
(99.1 %id)
CR748301   .b 415 to 1146 1 to 731       731/731
(100 %)
2 diff
(99.8 %id)
BU542743 carcinoma, cell line, Prostate .b 426 to 1299 1 to 883       883/902
(97 %)
21 diff
(97.7 %id)
AK000918 whole embryo, mainly head .b 436 to 1661 354 to 1579   available from FLJ,   1226/1579
(77 %)
4 diff
(99.8 %id)
BP260674 small intestine .b 437 to 1018 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BP261413 small intestine .b 437 to 1016 1 to 580       580/580
(100 %)
0 diff
(100 %id)
BM791269 stomach .b 448 to 1135 1 to 686       686/686
(100 %)
2 diff
(99.8 %id)
BM856822 stomach .b 448 to 844 1 to 397       397/397
(100 %)
0 diff
(100 %id)
TI_154179302   .b 449 to 1321 72 to 936       865/866
(99 %)
41 diff
(95.3 %id)
CN276177 embryonic stem cells, DMSO-treated H9 cellline .b 450 to 885 1 to 436       436/436
(100 %)
0 diff
(100 %id)
TI_154162526   .b 516 to 1096 81 to 659       579/585
(98 %)
16 diff
(97.3 %id)
AA639217 Ewing's sarcoma .b 536 to 847 354 to 43       312/361
(86 %)
5 diff
(98.7 %id)
TI_149285340   .b 551 to 1347 879 to 87   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 793/824
(96 %)
11 diff
(98.7 %id)
BE716838 head_neck .b 554 to 760 231 to 25       207/234
(88 %)
5 diff
(97.9 %id)
BY994687   .b 634 to 1306 7 to 679       673/679
(99 %)
0 diff
(100 %id)
EL953579 eyeball .b 635 to 1270 19 to 652       634/652
(97 %)
4 diff
(99.4 %id)
DT220342 brain .b 660 to 1212 1 to 553       553/553
(100 %)
0 diff
(100 %id)
AA287076 germinal center B cell .b 686 to 1117 1 to 433       433/433
(100 %)
1 diff
(99.8 %id)
BM984860 lung .b 706 to 1347 657 to 16   AAA Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) 642/642
(100 %)
0 diff
(100 %id)
BG211423   .b 717 to 1524 1 to 809       809/809
(100 %)
2 diff
(99.8 %id)
TI_149310670   .b 778 to 1663 968 to 92   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 877/942
(93 %)
18 diff
(98.1 %id)
TI_227712669   .b 786 to 1664 986 to 127       860/1071
(80 %)
28 diff
(97.4 %id)
TI_149302896   .b 789 to 1663 925 to 64   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 862/966
(89 %)
18 diff
(98.2 %id)
BQ685461 ductal carcinoma, cell line, Pancreas .b 791 to 1598 1 to 813       813/905
(89 %)
12 diff
(98.7 %id)
BU169957 large cell carcinoma, lung .b 816 to 1661 1 to 847       847/851
(99 %)
11 diff
(98.8 %id)
CD617242   .b 817 to 1473 659 to 6       654/659
(99 %)
0 diff
(100 %id)
FN075178 breast carcinoma .b 863 to 940 1 to 77       77/77
(100 %)
3 diff
(96.2 %id)
TI_154045196   .b 891 to 1663 849 to 79   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 771/1010
(76 %)
4 diff
(99.7 %id)
TI_154113354   .b 891 to 1650 843 to 83   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 761/963
(79 %)
3 diff
(99.7 %id)
BG195818   .b 892 to 1640 763 to 13     Submitted on the opposite strand 751/764
(98 %)
0 diff
(100 %id)
TI_154051131   .b 919 to 1663 821 to 84   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 738/938
(78 %)
39 diff
(95.9 %id)
CD369068 Alveolar Macrophage, lung .b 938 to 1663 742 to 17   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 726/726
(100 %)
0 diff
(100 %id)
AW802643 uterus .b 950 to 1236 287 to 1       287/287
(100 %)
21 diff
(92.7 %id)
BM981009 lung, Primary Lung Cystic Fibrosis EpithelialCells .b 950 to 1663 731 to 17   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 715/715
(100 %)
1 diff
(99.9 %id)
AW963414   .b 956 to 1649 693 to 1     Submitted on the opposite strand 693/693
(100 %)
16 diff
(97.7 %id)
CX868851 embryonic stem .b 961 to 1661 725 to 25   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 701/701
(100 %)
0 diff
(100 %id)
FN149083 breast carcinoma .b 976 to 1071 96 to 1     Submitted on the opposite strand 96/96
(100 %)
2 diff
(98.0 %id)
CX867331 embryonic stem .b 992 to 1661 696 to 26   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 671/671
(100 %)
1 diff
(99.9 %id)
BG196846   .b 994 to 1641 662 to 15     Submitted on the opposite strand 648/887
(73 %)
0 diff
(100 %id)
TI_149288789   .b 998 to 1651 797 to 141       657/841
(78 %)
0 diff
(100 %id)
CA412040 Chondrosarcoma Grade II, Left Pelvis .b 998 to 1663 683 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 665/665
(100 %)
1 diff
(99.9 %id)
BF095653 uterus_tumor .b 1001 to 1273 273 to 1       273/277
(98 %)
10 diff
(96.4 %id)
DA368304 subthalamic nucleus .b 1026 to 1588 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
TI_157611299   .b 1037 to 1663 706 to 80   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 627/627
(100 %)
1 diff
(99.9 %id)
BG939707 bone marrow stroma .b 1045 to 1650 618 to 13   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 606/606
(100 %)
0 diff
(100 %id)
CA776260 Pancreas, Purified pancreatic islet .b 1045 to 1650 606 to 1       606/606
(100 %)
0 diff
(100 %id)
BQ027194 lung, Metastatic Chondrosarcoma .b 1047 to 1663 633 to 17   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 617/617
(100 %)
0 diff
(100 %id)
BE621408 epithelioid carcinoma, Pancreas .b 1057 to 1645 589 to 1     Submitted on the opposite strand 589/662
(88 %)
14 diff
(97.9 %id)
TI_151732965   .b 1057 to 1650 676 to 84   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 593/931
(63 %)
16 diff
(98.3 %id)
BG184978   .b 1061 to 1641 631 to 52     Submitted on the opposite strand 580/886
(65 %)
0 diff
(100 %id)
BG195347   .b 1067 to 1641 589 to 16     Submitted on the opposite strand 574/920
(62 %)
0 diff
(100 %id)
TI_149273917   .b 1067 to 1661 58 to 651     Submitted on the opposite strand 594/943
(62 %)
17 diff
(98.2 %id)
BG195348   .b 1071 to 1641 583 to 14     Submitted on the opposite strand 570/829
(68 %)
0 diff
(100 %id)
AW934921 denis_drash .b 1075 to 1277 208 to 7     Submitted on the opposite strand 202/210
(96 %)
0 diff
(100 %id)
BM968324 lung, Primary Lung Epithelial Cells .b 1075 to 1560 1 to 485     Submitted on the opposite strand 485/485
(100 %)
6 diff
(98.8 %id)
BG191272   .b 1076 to 1641 616 to 51   AAA Submitted on the opposite strand 566/878
(64 %)
0 diff
(100 %id)
CN276169 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 1078 to 1661 1 to 584   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 584/584
(100 %)
0 diff
(100 %id)
TI_149272965   .b 1078 to 1653 668 to 94   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 575/834
(68 %)
1 diff
(99.9 %id)
CK902816 Pancreas, Purified pancreatic islet .b 1083 to 1648 566 to 1     Submitted on the opposite strand 566/566
(100 %)
0 diff
(100 %id)
AI298901 carcinoid, lung .b 1088 to 1516 1 to 429     Submitted on the opposite strand 429/429
(100 %)
0 diff
(100 %id)
FN125080 breast carcinoma .b 1089 to 1161 1 to 71       71/75
(94 %)
4 diff
(94.7 %id)
AV716093   .b 1092 to 1650 1 to 559   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 559/562
(99 %)
1 diff
(99.9 %id)
AI093465 uterus .b 1093 to 1531 1 to 439     Submitted on the opposite strand 439/439
(100 %)
0 diff
(100 %id)
CB133873 Liver .b 1096 to 1658 562 to 1     Submitted on the opposite strand 562/562
(100 %)
2 diff
(99.7 %id)
BF918005 uterus_tumor .b 1117 to 1570 454 to 1     Submitted on the opposite strand 454/464
(97 %)
4 diff
(99.2 %id)
AW517714 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 1118 to 1621 504 to 1       504/504
(100 %)
0 diff
(100 %id)
AI095475 uterus .b 1119 to 1645 527 to 1       527/527
(100 %)
0 diff
(100 %id)
BG949718 breast_normal .b 1121 to 1277 167 to 9       159/167
(95 %)
0 diff
(100 %id)
BF034332 adenocarcinoma, ovary .b 1122 to 1653 571 to 26     Submitted on the opposite strand 546/756
(72 %)
0 diff
(100 %id)
CV320908 lung_normal .b 1129 to 1365 240 to 1     Submitted on the opposite strand 240/240
(100 %)
17 diff
(93.0 %id)
BF851946 lung_normal .b 1130 to 1380 256 to 2     Submitted on the opposite strand 255/256
(99 %)
0 diff
(100 %id)
AI186804 lung .b 1133 to 1662 530 to 1       530/530
(100 %)
0 diff
(100 %id)
TI_149283972   .b 1136 to 1663 612 to 85   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 528/716
(73 %)
0 diff
(100 %id)
AW837764 leiomios .b 1140 to 1270 1 to 131       131/131
(100 %)
8 diff
(93.9 %id)
AW275936 lung, two pooled squamous cell carcinomas .b 1156 to 1664 509 to 1       509/509
(100 %)
0 diff
(100 %id)
EY123319 intestinal (Lauren) gastric adenocarcinoma, stomach .b 1164 to 1573 1 to 410       410/410
(100 %)
0 diff
(100 %id)
AL037853 brain .b 1166 to 1661 1 to 496   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 496/496
(100 %)
2 diff
(99.6 %id)
DB544137 hippocampus .b 1175 to 1650 1 to 476     Submitted on the opposite strand 476/476
(100 %)
0 diff
(100 %id)
AA553414 Schwannoma tumor .b 1179 to 1661 483 to 1       483/483
(100 %)
0 diff
(100 %id)
AA833795 germinal center B cell .b 1182 to 1662 490 to 10       481/490
(98 %)
0 diff
(100 %id)
AA969237 pooled .b 1182 to 1664 483 to 1       483/483
(100 %)
0 diff
(100 %id)
AI160120 brain, glioblastoma (pooled) .b 1187 to 1664 478 to 1       478/478
(100 %)
0 diff
(100 %id)
DB569176 hypothalamus .b 1191 to 1658 1 to 468     Submitted on the opposite strand 468/470
(99 %)
3 diff
(99.4 %id)
FN155994 breast carcinoma .b 1194 to 1295 99 to 1     Submitted on the opposite strand 99/99
(100 %)
3 diff
(97.0 %id)
CB135448 Liver .b 1194 to 1658 464 to 1     Submitted on the opposite strand 464/464
(100 %)
1 diff
(99.8 %id)
DA807413 brain .b 1198 to 1759 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA115170 cerebellum .b 1199 to 1764 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DB564629 hypothalamus .b 1199 to 1661 1 to 463     Submitted on the opposite strand 463/463
(100 %)
0 diff
(100 %id)
DB521380 testis .b 1201 to 1661 1 to 461     Submitted on the opposite strand 461/461
(100 %)
0 diff
(100 %id)
DB524122 testis .b 1208 to 1661 1 to 454     Submitted on the opposite strand 454/454
(100 %)
1 diff
(99.8 %id)
DB567311 hypothalamus .b 1212 to 1661 1 to 450     Submitted on the opposite strand 450/450
(100 %)
0 diff
(100 %id)
AI469498 colon, moderately-differentiated adenocarcinoma .b 1213 to 1626 414 to 1       414/414
(100 %)
0 diff
(100 %id)
AI276053 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 1214 to 1662 449 to 1       449/449
(100 %)
0 diff
(100 %id)
FN098992 breast carcinoma .b 1215 to 1295 1 to 78       78/87
(89 %)
6 diff
(93.2 %id)
FN171864 breast carcinoma .b 1219 to 1310 91 to 1     Submitted on the opposite strand 91/92
(98 %)
2 diff
(97.9 %id)
AA577316 colon, colon tumor RER+ .b 1219 to 1625 407 to 1       407/407
(100 %)
0 diff
(100 %id)
FN048862 breast carcinoma .b 1221 to 1287 1 to 66       66/66
(100 %)
3 diff
(95.5 %id)
DB549420 hippocampus .b 1223 to 1661 1 to 439     Submitted on the opposite strand 439/439
(100 %)
0 diff
(100 %id)
DB553618 hypothalamus .b 1224 to 1660 1 to 437     Submitted on the opposite strand 437/437
(100 %)
0 diff
(100 %id)
AI363029 anaplastic oligodendroglioma, brain .b 1225 to 1663 439 to 1       439/439
(100 %)
0 diff
(100 %id)
FN089419 breast carcinoma .b 1229 to 1295 67 to 1     Submitted on the opposite strand 67/68
(98 %)
2 diff
(97.1 %id)
DB547343 hippocampus .b 1232 to 1661 1 to 430     Submitted on the opposite strand 430/430
(100 %)
0 diff
(100 %id)
FN090266 breast carcinoma .b 1235 to 1332 98 to 1     Submitted on the opposite strand 98/98
(100 %)
0 diff
(100 %id)
AI242421 follicular lymphoma, lymph node .b 1243 to 1663 435 to 15   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 421/421
(100 %)
0 diff
(100 %id)
DA810704 brain .b 1243 to 1767 2 to 526   capped   525/525
(100 %)
0 diff
(100 %id)
FN116333 breast carcinoma .b 1245 to 1349 1 to 102       102/102
(100 %)
3 diff
(97.1 %id)
AA554323 colon .b 1247 to 1652 406 to 1       406/406
(100 %)
0 diff
(100 %id)
FN056574 breast carcinoma .b 1249 to 1349 101 to 1     Submitted on the opposite strand 101/101
(100 %)
0 diff
(100 %id)
AA926759 pooled .b 1250 to 1663 414 to 1       414/414
(100 %)
0 diff
(100 %id)
FN130206 breast carcinoma .b 1251 to 1347 97 to 1     Submitted on the opposite strand 97/98
(98 %)
2 diff
(98.0 %id)
AA773516 lung, lung carcinoma .b 1255 to 1661 407 to 1       407/407
(100 %)
0 diff
(100 %id)
DN914448   .b 1256 to 1650 394 to 1       394/394
(100 %)
2 diff
(99.5 %id)
FN082750 breast carcinoma .b 1258 to 1316 59 to 1     Submitted on the opposite strand 59/60
(98 %)
1 diff
(98.4 %id)
BF447534 sympathetic trunk .b 1259 to 1650 392 to 1       392/392
(100 %)
0 diff
(100 %id)
AA808249 germinal center B cell .b 1261 to 1661 419 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 401/401
(100 %)
0 diff
(100 %id)
CD171781 testis .b 1262 to 2098 1 to 841       841/866
(97 %)
11 diff
(98.8 %id)
FN054684 breast carcinoma .b 1265 to 1365 101 to 1     Submitted on the opposite strand 101/101
(100 %)
0 diff
(100 %id)
FN111416 breast carcinoma .b 1274 to 1339 68 to 1     Submitted on the opposite strand 68/69
(98 %)
2 diff
(97.2 %id)
AI253632 Prostate .b 1274 to 1661 388 to 1       388/388
(100 %)
0 diff
(100 %id)
AI803133 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 1274 to 1664 391 to 1       391/391
(100 %)
0 diff
(100 %id)
AI803581 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 1274 to 1663 402 to 13   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 390/390
(100 %)
0 diff
(100 %id)
AI471813 follicular lymphoma, lymph node .b 1275 to 1663 403 to 15   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 389/389
(100 %)
0 diff
(100 %id)
FN059110 breast carcinoma .b 1279 to 1393 1 to 114       114/114
(100 %)
1 diff
(99.2 %id)
FN060084 breast carcinoma .b 1279 to 1388 1 to 110       110/118
(93 %)
0 diff
(100 %id)
FN166462 breast carcinoma .b 1282 to 1395 112 to 1     Submitted on the opposite strand 112/114
(98 %)
2 diff
(98.3 %id)
AA287077 germinal center B cell .b 1283 to 1663 381 to 1       381/381
(100 %)
0 diff
(100 %id)
FN050816 breast carcinoma .b 1289 to 1412 124 to 1     Submitted on the opposite strand 124/124
(100 %)
0 diff
(100 %id)
FN171871 breast carcinoma .b 1293 to 1420 125 to 1     Submitted on the opposite strand 125/125
(100 %)
3 diff
(97.6 %id)
FN085429 breast carcinoma .b 1296 to 1380 1 to 84       84/85
(98 %)
3 diff
(96.5 %id)
FN111545 breast carcinoma .b 1297 to 1420 1 to 119       119/119
(100 %)
5 diff
(95.8 %id)
FN092888 breast carcinoma .b 1302 to 1427 126 to 1     Submitted on the opposite strand 126/126
(100 %)
0 diff
(100 %id)
FN087376 breast carcinoma .b 1317 to 1397 1 to 81       81/82
(98 %)
1 diff
(98.8 %id)
FN061571 breast carcinoma .b 1318 to 1394 73 to 1     Submitted on the opposite strand 73/73
(100 %)
3 diff
(95.9 %id)
FN144674 breast carcinoma .b 1318 to 1441 122 to 1     Submitted on the opposite strand 122/122
(100 %)
2 diff
(98.4 %id)
FN168859 breast carcinoma .b 1321 to 1384 65 to 1     Submitted on the opposite strand 65/66
(98 %)
1 diff
(98.5 %id)
DA041880 bladder .b 1322 to 1896 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
FN176385 breast carcinoma .b 1325 to 1439 1 to 114       114/117
(97 %)
2 diff
(98.3 %id)
TI_149284765   .b 1328 to 1663 416 to 82   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 335/1081
(30 %)
1 diff
(100.0 %id)
FN089542 breast carcinoma .b 1341 to 1456 1 to 113       113/113
(100 %)
3 diff
(97.4 %id)
FN144263 breast carcinoma .b 1348 to 1459 1 to 112       112/112
(100 %)
0 diff
(100 %id)
FN076827 breast carcinoma .b 1358 to 1469 110 to 1     Submitted on the opposite strand 110/110
(100 %)
1 diff
(99.1 %id)
FN168797 breast carcinoma .b 1358 to 1468 1 to 110       110/110
(100 %)
1 diff
(99.1 %id)
AA640332 alveolar rhabdomyosarcoma .b 1360 to 1622 269 to 6       264/278
(94 %)
0 diff
(100 %id)
FN123727 breast carcinoma .b 1376 to 1490 1 to 109       109/109
(100 %)
6 diff
(94.5 %id)
FN165048 breast carcinoma .b 1377 to 1488 110 to 1     Submitted on the opposite strand 110/110
(100 %)
2 diff
(98.2 %id)
FN084461 breast carcinoma .b 1383 to 1480 1 to 99       99/100
(99 %)
2 diff
(98.0 %id)
FN114752 breast carcinoma .b 1388 to 1489 113 to 11     Submitted on the opposite strand 103/114
(90 %)
0 diff
(100 %id)
FN068623 breast carcinoma .b 1394 to 1474 1 to 84       84/85
(98 %)
4 diff
(95.3 %id)
FN143365 breast carcinoma .b 1394 to 1499 1 to 103       103/103
(100 %)
3 diff
(97.1 %id)
FN139635 breast carcinoma .b 1396 to 1457 63 to 1     Submitted on the opposite strand 63/64
(98 %)
1 diff
(98.5 %id)
FN132256 breast carcinoma .b 1401 to 1489 7 to 100       94/104
(90 %)
7 diff
(93.3 %id)
FN067380 breast carcinoma .b 1409 to 1521 1 to 114       114/114
(100 %)
1 diff
(99.2 %id)
FN118532 breast carcinoma .b 1409 to 1516 110 to 1     Submitted on the opposite strand 110/110
(100 %)
2 diff
(98.2 %id)
FN064147 breast carcinoma .b 1414 to 1518 1 to 99       99/101
(98 %)
7 diff
(93.1 %id)
FN132887 breast carcinoma .b 1417 to 1517 101 to 1     Submitted on the opposite strand 101/101
(100 %)
10 diff
(90.1 %id)
FN172829 breast carcinoma .b 1418 to 1534 1 to 116       116/116
(100 %)
1 diff
(99.2 %id)
FN150371 breast carcinoma .b 1421 to 1523 1 to 101       101/111
(90 %)
6 diff
(94.6 %id)
FN119636 breast carcinoma .b 1423 to 1533 1 to 116       116/119
(97 %)
7 diff
(94.2 %id)
FN090285 breast carcinoma .b 1424 to 1485 1 to 61       61/63
(96 %)
3 diff
(95.3 %id)
FN177583 breast carcinoma .b 1425 to 1540 1 to 116       116/116
(100 %)
1 diff
(99.2 %id)
FN080072 breast carcinoma .b 1430 to 1491 63 to 1     Submitted on the opposite strand 63/64
(98 %)
2 diff
(96.9 %id)
FN090096 breast carcinoma .b 1439 to 1512 10 to 83       74/84
(88 %)
3 diff
(96.5 %id)
FN157684 breast carcinoma .b 1439 to 1547 1 to 110       110/110
(100 %)
2 diff
(98.2 %id)
FN058502 breast carcinoma .b 1444 to 1556 114 to 2     Submitted on the opposite strand 113/114
(99 %)
0 diff
(100 %id)
FN062810 breast carcinoma .b 1471 to 1557 1 to 86       86/86
(100 %)
2 diff
(97.7 %id)
FN065901 breast carcinoma .b 1476 to 1593 1 to 118       118/118
(100 %)
0 diff
(100 %id)
AA372237 epithelium, retina pigmented layer .b 1477 to 1650 174 to 1     Submitted on the opposite strand 174/174
(100 %)
0 diff
(100 %id)
T03741   .b 1477 to 1626 150 to 1       150/150
(100 %)
3 diff
(98.0 %id)
FN124201 breast carcinoma .b 1486 to 1601 1 to 114       114/114
(100 %)
8 diff
(93.0 %id)
FN053690 breast carcinoma .b 1496 to 1556 63 to 1     Submitted on the opposite strand 63/63
(100 %)
2 diff
(96.9 %id)
FN099751 breast carcinoma .b 1504 to 1616 1 to 116       116/116
(100 %)
3 diff
(97.5 %id)
FN055226 breast carcinoma .b 1515 to 1591 78 to 1     Submitted on the opposite strand 78/79
(98 %)
1 diff
(98.8 %id)
FN087130 breast carcinoma .b 1523 to 1631 106 to 1     Submitted on the opposite strand 106/111
(95 %)
4 diff
(96.4 %id)
FN169885 breast carcinoma .b 1529 to 1647 114 to 1     Submitted on the opposite strand 114/114
(100 %)
4 diff
(96.5 %id)
FN054414 breast carcinoma .b 1532 to 1626 1 to 95       95/95
(100 %)
1 diff
(99.0 %id)
FN084302 breast carcinoma .b 1533 to 1594 63 to 1     Submitted on the opposite strand 63/64
(98 %)
2 diff
(96.9 %id)
CX873072 embryonic stem .b 1551 to 2383 1 to 833       833/833
(100 %)
0 diff
(100 %id)
FN084708 breast carcinoma .b 1569 to 1655 83 to 1     Submitted on the opposite strand 83/84
(98 %)
2 diff
(97.7 %id)
AK024299   .b 1642 to 4522 1 to 2879   tiling clone, available from FLJ,   2879/2879
(100 %)
10 diff
(99.7 %id)
AU132774   .b 1643 to 2457 2 to 819   capped   818/851
(96 %)
4 diff
(99.6 %id)
DA285924 corpus callosum .b 1651 to 2136 2 to 487   capped   486/486
(100 %)
0 diff
(100 %id)
DA538813 Kidney .b 1670 to 2258 2 to 590   capped   589/589
(100 %)
0 diff
(100 %id)
BM698544 eye, fetal eyes .b 1772 to 2155 1 to 385     Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 385/385
(100 %)
1 diff
(99.8 %id)
FN069880 breast carcinoma .b 1912 to 2007 93 to 1     Submitted on the opposite strand 93/94
(98 %)
6 diff
(93.7 %id)
FN177533 breast carcinoma .b 1912 to 2007 97 to 1     Submitted on the opposite strand 97/97
(100 %)
1 diff
(99.0 %id)
BM480367 duodenal adenocarcinoma, cell line, small intestine .b 2018 to 3028 1 to 1019       1019/1022
(99 %)
24 diff
(97.7 %id)
CR610939 Placenta Cot 25-normalized .b 2103 to 3539 1 to 1437   tiling clone,   1437/1437
(100 %)
0 diff
(100 %id)
AL546692 placenta, Placenta Cot 25-normalized .b 2103 to 3009 1 to 899   fully sequenced,   899/899
(100 %)
2 diff
(99.8 %id)
DA231549 brain .b 2328 to 2867 2 to 541   capped   540/540
(100 %)
1 diff
(99.9 %id)
BY995181   .b 2380 to 3115 10 to 745       736/745
(98 %)
0 diff
(100 %id)
FN134551 breast carcinoma .b 2462 to 2555 97 to 5     Submitted on the opposite strand 93/97
(95 %)
0 diff
(100 %id)
AL565675 brain, fetal brain .b 2507 to 3553 1034 to 1       1034/1034
(100 %)
25 diff
(97.6 %id)
FN158129 breast carcinoma .b 2610 to 2703 92 to 1     Submitted on the opposite strand 92/98
(93 %)
1 diff
(99.0 %id)
TI_57198516   .b 2675 to 3512 105 to 939       835/941
(88 %)
10 diff
(99.0 %id)
TI_149293382   .b 2719 to 3572 921 to 79   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 843/967
(87 %)
18 diff
(98.2 %id)
FN049392 breast carcinoma .b 2812 to 2886 75 to 1     Submitted on the opposite strand 75/75
(100 %)
0 diff
(100 %id)
FN152297 breast carcinoma .b 2848 to 2976 128 to 1     Submitted on the opposite strand 128/128
(100 %)
4 diff
(96.9 %id)
TI_154038883   .b 2854 to 3572 799 to 83   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 717/795
(90 %)
15 diff
(98.2 %id)
BM727312 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 2856 to 3295 1 to 440   fully sequenced, Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 440/440
(100 %)
0 diff
(100 %id)
CA421447 Chondrosarcoma Grade II, Left Pelvis .b 2864 to 3572 726 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 708/710
(99 %)
2 diff
(99.8 %id)
TI_154099612   .b 2867 to 3569 797 to 95   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 703/704
(99 %)
7 diff
(99.1 %id)
BM975121 lung .b 2873 to 3572 718 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 700/700
(100 %)
1 diff
(99.9 %id)
AW002169 thymus, pooled .b 2899 to 3325 1 to 427     Submitted on the opposite strand 427/427
(100 %)
0 diff
(100 %id)
BU680242 lung, Primary Lung Epithelial Cells .b 2956 to 3570 8 to 621     Submitted on the opposite strand 614/624
(98 %)
8 diff
(98.8 %id)
AA171992   .b 2967 to 3190 1 to 223     Submitted on the opposite strand 223/234
(95 %)
3 diff
(98.8 %id)
AL571942 placenta, Placenta Cot 25-normalized .b 2979 to 3539 553 to 1   fully sequenced,   553/553
(100 %)
4 diff
(99.3 %id)
BM667470 eye, fetal eyes .b 3029 to 3572 562 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 544/544
(100 %)
0 diff
(100 %id)
TI_149283552   .b 3032 to 3572 619 to 79   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 541/710
(76 %)
0 diff
(100 %id)
BU680198 lung, Primary Lung Epithelial Cells .b 3033 to 3572 558 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 540/544
(99 %)
0 diff
(100 %id)
CA444941 lung, Metastatic Chondrosarcoma .b 3033 to 3572 558 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 540/540
(100 %)
0 diff
(100 %id)
AW188421 colon, moderately differentiated adenocarcinoma .b 3045 to 3573 535 to 7       529/535
(98 %)
0 diff
(100 %id)
AI810011 pooled .b 3053 to 3574 538 to 17   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 522/522
(100 %)
0 diff
(100 %id)
AI299870 carcinoid, lung .b 3095 to 3550 456 to 1       456/456
(100 %)
0 diff
(100 %id)
FN143548 breast carcinoma .b 3098 to 3179 1 to 82       82/82
(100 %)
3 diff
(96.4 %id)
DB546971 hippocampus .b 3108 to 3563 1 to 456     Submitted on the opposite strand 456/458
(99 %)
2 diff
(99.6 %id)
AI805173 pooled .b 3129 to 3574 456 to 11   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 446/446
(100 %)
0 diff
(100 %id)
DA407716 thalamus .b 3158 to 3707 2 to 551   capped   550/550
(100 %)
1 diff
(99.9 %id)
AA828659 ovary .b 3258 to 3573 317 to 2       316/322
(98 %)
0 diff
(100 %id)
BM681688 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 3265 to 3572 326 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 308/308
(100 %)
0 diff
(100 %id)
AA828725 ovary .b 3270 to 3573 305 to 2       304/305
(99 %)
0 diff
(100 %id)
BE006615 breast_normal .b 3273 to 3546 276 to 4     Submitted on the opposite strand 273/283
(96 %)
0 diff
(100 %id)
FN084495 breast carcinoma .b 3288 to 3383 97 to 5     Submitted on the opposite strand 93/98
(94 %)
0 diff
(100 %id)
AA172308   .b 3300 to 3573 276 to 2     Submitted on the opposite strand 275/276
(99 %)
0 diff
(100 %id)
FN144382 breast carcinoma .b 3333 to 3428 1 to 97       97/97
(100 %)
1 diff
(99.0 %id)
DA440216 tongue, tumor tissue .b 3738 to 4309 2 to 573   tiling clone, capped   572/572
(100 %)
0 diff
(100 %id)
AJ714954 bone marrow .b 3740 to 3880 24 to 170       147/170
(86 %)
0 diff
(100 %id)
TI_154126153   .b 3808 to 4574 837 to 81   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 757/941
(80 %)
12 diff
(98.8 %id)
EB362541 eye, lens .b 3874 to 4567 724 to 32   AAA   693/700
(99 %)
0 diff
(100 %id)
AU154238   .b 3937 to 4522 583 to 1       583/584
(99 %)
10 diff
(98.3 %id)
BF195392 brain, glioblastoma (pooled) .b 4017 to 4515 499 to 1   tiling clone,   499/499
(100 %)
0 diff
(100 %id)
TI_57168119   .b 4268 to 5074 65 to 868       804/869
(92 %)
17 diff
(98.1 %id)
DB016150 esophageal, tumor tissue .b 4434 to 5004 2 to 572   tiling clone, capped   571/571
(100 %)
0 diff
(100 %id)
AK096868 rectum .b 4521 to 6412 1 to 1892   tiling clone, available from FLJ,   1892/1892
(100 %)
1 diff
(100.0 %id)
BI552851 brain, hippocampus .c 1 to 654 1 to 655 S112L E113R E114R N115K R116S ... tiling clone,   655/655
(100 %)
5 diff
(99.3 %id)
BG718237 testis .d 1 to 738 1 to 736 L121W G122E S123V G124E V125F tiling clone,   736/736
(100 %)
11 diff
(98.6 %id)
CB988262 Human Placenta, placenta .d 18 to 758 27 to 768 exact tiling clone,   742/768
(96 %)
2 diff
(99.8 %id)
BX367153   .d 35 to 951 1 to 931 A2I S3T A4D S5G G6V ...     931/931
(100 %)
34 diff
(96.4 %id)
DW455409 Liver .d 555 to 722 8 to 175       168/175
(96 %)
6 diff
(96.6 %id)
AA583976 larynx .d 806 to 1089 284 to 1   tiling clone,   284/284
(100 %)
0 diff
(100 %id)
DW447638 Liver .d 919 to 1081 17 to 179   AAA   163/180
(90 %)
2 diff
(98.9 %id)
BF988383 placenta_normal .d 964 to 1190 26 to 257   tiling clone,   232/266
(87 %)
12 diff
(95.5 %id)
BX367152   .d 1089 to 2027 947 to 1   tiling clone,   947/947
(100 %)
36 diff
(96.2 %id)
AK123434 hippocampus .e-u 1 to 3759 2 to 3760 P106R tiling clone, available from FLJ,   3760/3760
(100 %)
8 diff
(99.8 %id)
DA311679 hippocampus .e-u 1 to 566 2 to 568 S79F H81P Y82L I83H Y84I ... capped   567/567
(100 %)
4 diff
(99.3 %id)
DB279865 uterus .e-u 125 to 659 2 to 537   capped   536/536
(100 %)
3 diff
(99.5 %id)
DA412329 thalamus .e-u 363 to 937 2 to 576   tiling clone, capped   575/575
(100 %)
0 diff
(100 %id)
DA043384 bladder .e-u 467 to 1031 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
DA043426 bladder .e-u 467 to 1034 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
AL598488   .e-u 1068 to 1595 1 to 527       527/527
(100 %)
2 diff
(99.7 %id)
AV755797 bone marrow .e-u 1514 to 1947 66 to 498   tiling clone,   433/504
(85 %)
23 diff
(95.5 %id)
AL704131 human skeletal muscle .e-u 2079 to 2752 1 to 674       674/674
(100 %)
1 diff
(99.9 %id)
CR739785 lung .e-u 2419 to 2887 1 to 469   tiling clone,   469/469
(100 %)
0 diff
(100 %id)
FN102525 breast carcinoma .e-u 2667 to 2791 122 to 1     Submitted on the opposite strand 122/122
(100 %)
3 diff
(97.6 %id)
DB112093 thymus .e-u 2753 to 3325 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
BF528467 anaplastic oligodendroglioma with 1p/19qloss, brain .e-u 2984 to 3755 1 to 766       766/769
(99 %)
44 diff
(94.3 %id)
BX481512   .e-u 3191 to 3759 602 to 33   AAA Submitted on the opposite strand 570/570
(100 %)
1 diff
(99.9 %id)
DB308494 hippocampus .e-u 3209 to 3759 551 to 1       551/551
(100 %)
1 diff
(99.9 %id)
AI986082 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .e-u 3237 to 3688 453 to 1       453/453
(100 %)
5 diff
(98.9 %id)
AI332536 lung .e-u 3280 to 3758 478 to 1       478/478
(100 %)
1 diff
(99.8 %id)
AI040125 liver and spleen .e-u 3339 to 3759 421 to 1       421/421
(100 %)
0 diff
(100 %id)
AI240750 liver and spleen .e-u 3486 to 3759 274 to 1       274/274
(100 %)
1 diff
(99.7 %id)
AL712636 human skeletal muscle .e-u 3668 to 4209 1 to 542   tiling clone,   542/542
(100 %)
1 diff
(99.9 %id)
AA328043   .f 1 to 408 1 to 407 N14X L30X N86* tiling clone,   407/412
(98 %)
11 diff
(97.4 %id)
CB992784 placenta, pre-eclamptic placenta .g 1 to 572 27 to 605 exact tiling clone,   579/922
(62 %)
14 diff
(98.5 %id)
CB995536 placenta, pre-eclamptic placenta .g 1 to 651 27 to 679 exact tiling clone,   653/860
(75 %)
12 diff
(98.7 %id)
BM472801 duodenal adenocarcinoma, cell line, small intestine .h-u 1 to 848 1 to 854 H41P E53Q T55P A62V Y69L ... tiling clone,   854/1032
(82 %)
33 diff
(96.9 %id)
AA385696 thyroid gland .h-u 176 to 417 1 to 242       242/245
(98 %)
3 diff
(98.8 %id)
AW951557   .h-u 177 to 681 1 to 506   tiling clone,   506/510
(99 %)
18 diff
(96.5 %id)
DA392465 thalamus .i 1 to 566 2 to 567 exact tiling clone, capped   566/566
(100 %)
0 diff
(100 %id)
DA470967   .j-u 1 to 562 2 to 563 exact tiling clone, capped   562/562
(100 %)
0 diff
(100 %id)
BI668064 brain, hypothalamus .j-u 170 to 963 1 to 796   available from MGC,   796/796
(100 %)
16 diff
(98.0 %id)
TI_44346473   .j-u 174 to 963 86 to 877       792/877
(90 %)
14 diff
(98.5 %id)
BC042860 Brain, hypothalamus .j-u 175 to 1782 1 to 1608   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 1608/1610
(99 %)
1 diff
(100.0 %id)
F12325 brain, total brain .j-u 340 to 657 1 to 318       318/318
(100 %)
0 diff
(100 %id)
BI596952 brain, hypothalamus .j-u 754 to 1475 1 to 721   available from MGC,   721/721
(100 %)
8 diff
(98.9 %id)
TI_45208859   .j-u 758 to 1475 91 to 807       717/807
(88 %)
0 diff
(100 %id)
BC033947 Brain, hypothalamus .j-u 759 to 1926 1 to 1168   available from MGC, AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 1168/1168
(100 %)
0 diff
(100 %id)
AW901896 nervous_normal .j-u 954 to 1181 258 to 32       227/269
(84 %)
0 diff
(100 %id)
BE936160 nervous_normal .j-u 954 to 1195 249 to 9       241/260
(92 %)
0 diff
(100 %id)
BF364032 nervous_normal .j-u 954 to 1195 250 to 10       241/261
(92 %)
0 diff
(100 %id)
BU101862   .j-u 1043 to 1665 624 to 1       624/624
(100 %)
5 diff
(99.2 %id)
AW975740   .j-u 1053 to 1778 727 to 1     Submitted on the opposite strand 727/760
(95 %)
5 diff
(99.4 %id)
TI_154134800   .j-u 1249 to 1926 778 to 96   AAA Possibly primed on the genome, locally A rich (26/26 A in genome downstream of last aligned base) 683/1108
(61 %)
72 diff
(93.6 %id)
BM713168 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .j-u 1265 to 1779 1 to 515   fully sequenced, AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 515/515
(100 %)
0 diff
(100 %id)
FN081169 breast carcinoma .j-u 1326 to 1397 72 to 1     Submitted on the opposite strand 72/73
(98 %)
0 diff
(100 %id)
AA576096 breast, breast tumor .j-u 1354 to 1784 431 to 1       431/431
(100 %)
0 diff
(100 %id)
AA043615 uterus .j-u 1463 to 1889 1 to 429   fully sequenced, AAA   429/429
(100 %)
2 diff
(99.6 %id)
CR741019 uterus .j-u 1464 to 2111 1 to 647   tiling clone,   647/649
(99 %)
2 diff
(99.7 %id)
F09949 brain, total brain .j-u 1481 to 1779 299 to 1       299/299
(100 %)
2 diff
(99.4 %id)
BM675036 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .j-u 1507 to 1779 289 to 17   fully sequenced, AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 273/273
(100 %)
0 diff
(100 %id)
AA043257 uterus .j-u 1859 to 2226 369 to 1   tiling clone, fully sequenced,   369/369
(100 %)
2 diff
(99.5 %id)
AI797341 pooled .j-u 1925 to 2226 307 to 9       299/319
(93 %)
0 diff
(100 %id)
AI277492 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .k-u 1 to 347 347 to 1 exact tiling clone,   347/347
(100 %)
0 diff
(100 %id)
AV711997   Gene VAPA, variant not shown       AAA Submitted on the opposite strand, submitted on the opposite strand    
BE700324 nervous_normal Gene VAPA, variant not shown              
AV707230 adrenal gland Gene VAPA, variant not shown              
AV712526   Gene VAPA, variant not shown       AAA Submitted on the opposite strand, submitted on the opposite strand    
AV725332 hypothalamus Gene VAPA, variant not shown         Suspected internal deletion, this clone was ignored    
AW888609 nervous_tumor Gene VAPA, variant not shown         This clone was ignored    
R96621 liver and spleen Gene VAPA, variant not shown         This clone was ignored    
R96662 liver and spleen Gene VAPA, variant not shown         This clone was ignored    
AW103251 ovary, tumor, 5 pooled (see description) Gene VAPA, variant not shown              
TI_44342810   Gene VAPA, variant not shown         Suspected internal deletion, this clone was ignored    
DA951471 Spleen Gene VAPA, variant not shown       capped      
DB333778 Spleen Gene VAPA, variant not shown              
TI_149296214   Gene VAPA, variant not shown       AAA Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e-u, .f, .g, .h-u, .i, .j-u, .k-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI